BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17998878)

  • 1. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.
    Bueno V; Binet I; Steger U; Bundick R; Ferguson D; Murray C; Donald D; Wood K
    Transplantation; 2007 Nov; 84(9):1204-7. PubMed ID: 17998878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor.
    Påhlman C; Malm H; Qi Z; Veress B; Ferguson D; Bundick R; Murray C; Donald D; Ekberg H
    Transplantation; 2008 Oct; 86(8):1135-8. PubMed ID: 18946353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
    Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
    Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism analysis of long-term graft survival by monocarboxylate transporter-1 inhibition.
    Cho KS; Yamada T; Wynn C; Behanna HA; Hong IC; Manaves V; Nakanishi T; Hirose J; Abe Y; Jiang H; Tamura K; Saita Y
    Transplantation; 2010 Dec; 90(12):1299-306. PubMed ID: 21076380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
    Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist.
    Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M
    Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1.
    Påhlman C; Qi Z; Murray CM; Ferguson D; Bundick RV; Donald DK; Ekberg H
    Transpl Int; 2013 Jan; 26(1):22-9. PubMed ID: 23137339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
    Wang S; Diao H; Guan Q; Jevnikar AM; Du C
    Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.
    Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS
    Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of fully mismatched cardiac allografts and generation of regulatory cells by Sairei-to, a Japanese herbal medicine.
    Zhang Q; Iwami D; Aramaki O; Yakubo S; Nishimura K; Ishige A; Watanabe K; Matsuno K; Shirasugi N; Niimi M
    Transplantation; 2009 Jun; 87(12):1787-91. PubMed ID: 19543054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.